Broussonetia papyrifera Polysaccharide Alleviated Acetaminophen-Induced Liver Injury by Regulating the Intestinal Flora

Nutrients. 2022 Jun 25;14(13):2636. doi: 10.3390/nu14132636.

Abstract

Liver injury caused by an overdose of acetaminophen (APAP) is a major public health problem. This study aimed to evaluate the effects of Broussonetia papyrifera polysaccharide (BPP) on liver injury and intestinal flora induced by APAP. The results showed that BPP could protect against APAP-induced liver injury, alleviate liver apoptosis, improve antioxidant capacity and enhance the liver's detoxification ability to APAP. At the same time, BPP improved the intestinal flora disorder caused by APAP. More importantly, we found that the hepatoprotective effect of BPP disappeared after the depletion of gut microbiota in mice. Further, we reconstructed the intestinal flora structure of mice through fecal microbiota transplantation and found that the symptoms of APAP-induced liver injury were effectively alleviated. Overall, BPP was a potential hepatoprotective drug that could protect against APAP-induced liver injury and might be mediated by intestinal flora.

Keywords: Broussonetia papyrifera polysaccharide; intestinal flora; liver injury.

MeSH terms

  • Acetaminophen / toxicity
  • Animals
  • Broussonetia*
  • Chemical and Drug Induced Liver Injury* / metabolism
  • Chemical and Drug Induced Liver Injury* / prevention & control
  • Chemical and Drug Induced Liver Injury, Chronic*
  • Gastrointestinal Microbiome*
  • Liver / metabolism
  • Mice
  • Oxidative Stress
  • Polysaccharides / metabolism
  • Polysaccharides / pharmacology
  • Polysaccharides / therapeutic use

Substances

  • Polysaccharides
  • Acetaminophen